FDA Approved: PROCRIT — Supplemental Application (Janssen Products, LP)

View source ↗

Summary

FDA approved a supplemental application for PROCRIT (epoetin alfa) submitted by Janssen Products, LP.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia Due to Chronic Kidney Disease
• Anemia in HIV Infection Treated with Zidovudine
• Chemotherapy-induced Anemia

Drugs mentioned

• PROCRIT (ERYTHROPOIETIN)

Snippet

SUPPL AP for PROCRIT (ERYTHROPOIETIN)